EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study

Anya Ragnhildstveit, Ryan Khan, Paul Seli, Lisa Claire Bass, River Jude August, Miriam Kaiyo, Nathaniel Barr, Laura Kate Jackson, Michael Santo Gaffrey, Joseph Peter Barsuglia, Lynnette Astrid Averill

Frontiers in Psychiatry · 23.11.2023 · 14

DOI: 10.3389/fpsyt.2023.1271152 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Psychiatry, online erschienen am 23.11.2023. Verfasst von Anya Ragnhildstveit und 10 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Research Literacy Group, Draper, UT, United States. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychedelic therapy is, arguably, the next frontier in psychiatry. It offers a radical alternative to longstanding, mainstays of treatment, while exciting a paradigm shift in translational science and drug discovery. There is particular interest in 5-methoxy- N,N -dimethyltryptamine (5-MeO-DMT)—a serotonergic psychedelic—as a novel, fast-acting therapeutic. Yet, few studies have directly examined 5-MeO-DMT for trauma- or stress-related psychopathology, including post-traumatic stress disorder (PTSD). Herein, we present the first longitudinal case study on 5-MeO-DMT for chronic refractory PTSD, in a 23-year-old female. A single dose of vaporized bufotoxin of the Sonoran Desert Toad ( Incilius alvarius ), containing an estimated 10−15 mg of 5-MeO-DMT, led to clinically significant improvements in PTSD, with next-day effects. This was accompanied by marked reductions in hopelessness and related suicide risk. Improvements, across all constructs, were sustained at 1-, 3-, 6-, and 12-months follow-up, as monitored by a supporting clinician. The subject further endorsed a complete mystical experience, hypothesized to underly 5-MeO-DMT’s therapeutic activity. No drug-related, serious adverse events occurred. Together, results showed that 5-MeO-DMT was generally tolerable, safe to administer, and effective for PTSD; however, this was not without risk. The subject reported acute nausea, overwhelming subjective effects, and late onset of night terrors. Further research is warranted to replicate and extend these findings, which are inherently limited, non-generalizable, and rely on methods not clinically accepted.

Schlagwörter

Stichwörter der Autor:innen

5-MeO-DMT5-methoxy-NN-dimethyltryptaminePTSDcase reportpost-traumatic stress disorderpsychedelic therapytrauma

Autor:innen und Institutionen

  • Integrated Research Literacy Group, Draper, UT, United States.
  • Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom.
  • Department of Psychology and Neuroscience, Duke University, Durham, NC, United States.
  • Neuroscience Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA, United States.
  • Department of Family and Consumer Studies, University of Utah, Salt Lake City, UT, United States.
  • School of Humanities and Creativity, Sheridan College, Oakville, ON, Canada.

Förderung

  • CSRD VA

Zitieren

APA

Ragnhildstveit, A., Khan, R., Seli, P., Bass, L. C., August, R. J., Kaiyo, M., Barr, N., Jackson, L. K., Gaffrey, M. S., Barsuglia, J. P., & Averill, L. A. (2023). 5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1271152

Vancouver

Ragnhildstveit A, Khan R, Seli P, Bass LC, August RJ, Kaiyo M, et al. 5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study. Frontiers in Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1271152

BibTeX
@article{Ragnhildstveit2023,
  author = {Ragnhildstveit, Anya and Khan, Ryan and Seli, Paul and Bass, Lisa Claire and August, River Jude and Kaiyo, Miriam and Barr, Nathaniel and Jackson, Laura Kate and Gaffrey, Michael Santo and Barsuglia, Joseph Peter and Averill, Lynnette Astrid},
  title = {5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study},
  journal = {Frontiers in Psychiatry},
  year = {2023},
  volume = {14},
  doi = {10.3389/fpsyt.2023.1271152}
}
Kostenlos starten →